You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Endoluminal radiofrequency ablation prior to stenting for malignant biliary obstruction: really time to say goodbye?
  1. Jia-Su Li1,
  2. Jun Fang2,
  3. Zhao-Shen Li1
  1. 1 Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China
  2. 2 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  1. Correspondence to Dr Zhao-Shen Li, Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai 200433, China; zhs.li{at}hotmail.com; Dr Jun Fang, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; drmurphy{at}126.com

https://doi.org/10.1136/gutjnl-2023-331070

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Recently, Jarosova et al 1 carried out a multicentre randomised trial to assess the impact of endoluminal radiofrequency ablation (RFA) plus stenting with stenting alone in patients with malignant biliary obstruction. The authors demonstrated that there was no benefit of endoluminal biliary RFA in patients with cholangiocarcinoma (CCA) and pancreatic cancer on survival or stent patency.

    Their results were in agreement with the only Western randomised controlled study conducted by Albers et al.2 We notice that hilar CCA accounted for a large proportion (85.9%, 73/85) in CCA arm of the current study while distal biliary strictures accounted for 62.8% (54/86) in the latter study. We believe that the type of tumour and the location of the stenosis may have some impact on overall …

    View Full Text

    Footnotes

    • Contributors JF and Z-SL conceived and designed the study. J-SL wrote the draft. All authors: final approval of the letter.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.